James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018).
Gan, Y. et al. Depression and the risk of coronary heart disease: A meta-analysis of prospective cohort studies. BMC Psychiatry 14, 11 (2014).
der Kooy, K. V. et al. Depression and the risk for cardiovascular diseases: Systematic review and meta analysis. Int. J. Geriatr. Psychiatry 22, 613–626 (2007).
Roth, G. A. et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
De Hert, M., Detraux, J. & Vancampfort, D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin. Neurosci. 20, 31–40 (2018).
Lippi, G., Montagnana, M., Favaloro, E. J. & Franchini, M. Mental depression and cardiovascular disease: A multifaceted, bidirectional association. Semin. Thromb. Hemost 35, 325–336 (2009).
Musselman, D. L., Evans, D. L. & Nemeroff, C. B. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry 55, 580–592 (1998).
Penninx, B. W. J. H. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci. Biobehav. Rev. 74, 277–286 (2017).
Bonnet, F. et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 178, 339–344 (2005).
Gangwisch, J. E. et al. Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am. J. Hypertens. 23, 62–69 (2010).
Hartka, E. et al. A meta-analysis of depressive symptomatology and alcohol consumption over time*. Br. J. Addict. 86, 1283–1298 (1991).
Koschke, M. et al. Autonomy of autonomic dysfunction in major depression. Psychosom. Med. 71, 852–860 (2009).
Crookes, D. M., Demmer, R. T., Keyes, K. M., Koenen, K. C. & Suglia, S. F. Depressive symptoms, antidepressant use, and hypertension in young adulthood. Epidemiology 29, 547–555 (2018).
Licht, C. M. M. et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53, 631–638 (2009).
Ginty, A. T., Carroll, D., Roseboom, T. J., Phillips, A. C. & de Rooij, S. R. Depression and anxiety are associated with a diagnosis of hypertension 5 years later in a cohort of late middle-aged men and women. J. Hum. Hypertens. 27, 187–190 (2013).
Pantell, M. S., Prather, A. A., Downing, J. M., Gordon, N. P. & Adler, N. E. Association of social and behavioral risk factors with earlier onset of adult hypertension and diabetes. JAMA Netw. Open 2, 10 (2019).
Räikkönen, K., Matthews, K. A. & Kuller, L. H. Trajectory of psychological risk and incident hypertension in middle-aged women. Hypertension 38, 798–802 (2001).
Meng, L., Chen, D., Yang, Y., Zheng, Y. & Hui, R. Depression increases the risk of hypertension incidence: A meta-analysis of prospective cohort studies. J. Hypertens. 30, 842 (2012).
Gromova, H. A., Gafarov, V. V. & Gagulin, I. V. Depression and risk of cardiovascular diseases among males aged 25–64 (WHO MONICA–psychosocial). Alaska Med. 49, 255–258 (2007).
Shinn, E. H. et al. Blood pressure and symptoms of depression and anxiety: A prospective study. Am. J. Hypertens. 14, 660–664 (2001).
Delaney, J. A. C. et al. Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: The Multi-Ethnic Study of Atherosclerosis. Hypertension 55, 408 (2010).
Everson, S. A., Kaplan, G. A., Goldberg, D. E. & Salonen, J. T. Hypertension incidence is predicted by high levels of hopelessness in finnish men. Hypertension 35, 561–567 (2000).
Jonas, B. S., Franks, P. & Ingram, D. D. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch. Fam. Med. 6, 43–49 (1997).
Yan, L. L. et al. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA 290, 2138–2148 (2003).
Meyer, C. M., Armenian, H. K., Eaton, W. W. & Ford, D. E. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study. J. Affect. Disord. 83, 127–133 (2004).
Patten, S. et al. Major depression as a risk factor for high blood pressure: epidemiologic evidence from a National Longitudinal Study. Psychosom. Med. 71, 273–279 (2009).
Vogt, T., Pope, C., Mullooly, J. & Hollis, J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am. J. Public Health 84, 227–231 (1994).
Tusa, N. et al. The profiles of health care utilization among a non-depressed population and patients with depressive symptoms with and without clinical depression. Scand. J. Prim. Health Care 37, 312–318 (2019).
Hildrum, B., Romild, U. & Holmen, J. Anxiety and depression lowers blood pressure: 22-year follow-up of the population based HUNT study, Norway. BMC Public Health 11, 601 (2011).
Speerforck, S. et al. 12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: A prospective cohort analysis in Germany. Eur. Arch. Psychiatry Clin. Neurosci. https://doi.org/10.1007/s00406-018-0923-1 (2018).
Shah, M. T., Zonderman, A. B. & Waldstein, S. R. Sex and age differences in the relation of depressive symptoms with blood pressure. Am J Hypertens 26, 1413–1420 (2013).
Ackermann-Liebrich, U. et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: Methods and characterization of participants. Soz.-Präventivmed. 50, 245–263 (2005).
Aebi, N. J. et al. Patterns of cross-sectional and predictive physical activity in Swiss adults aged 52+: results from the SAPALDIA cohort. Swiss Med. Weekly 150, 20 (2020).
Martin, B. W. et al. SAPALDIA: Methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 42, 67–84 (1997).
Ware, J., Kosinski, M. & Keller, S. SF-36 Physical and Mental Health Summary Scales: A Users’ Manual (The Health Institute, 1994).
Silveira, E. et al. Performance of the SF-36 health survey in screening for depressive and anxiety disorders in an elderly female Swedish population. Qual. Life Res. 14, 1263–1274 (2005).
Panczak, R. et al. A Swiss neighbourhood index of socioeconomic position: Development and association with mortality. J. Epidemiol. Commun. Health 66, 10 (2012).
Organisation mondiale de la santé. Global recommendations on physical activity for health. (WHO, 2010).
Johns, M. W. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14, 540–545 (1991).
Tobin, M. D., Sheehan, N. A., Scurrah, K. J. & Burton, P. R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat. Med. 24, 2911–2935 (2005).
Glymour, M. M., Weuve, J., Berkman, L. F., Kawachi, I. & Robins, J. M. When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am. J. Epidemiol. 162, 267–278 (2005).
Li, G.H.-Y. et al. Evaluation of bi-directional causal association between depression and cardiovascular diseases: a Mendelian randomization study. Psychol. Med. https://doi.org/10.1017/S0033291720003566 (2020).
Stahl, S. M. Blue genes and the monoamine hypothesis of depression. J. Clin. Psychiatry 61, 77–78 (2000).
Zhong, Z. et al. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis. Treat. 13, 2781–2796 (2017).
Davidson, J. R. T. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 71 Suppl E1, e04 (2010).
Baune, B. T. et al. The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl. Psychiatry 2, e92–e92 (2012).
Rantanen, A. T., Korkeila, J. J. A., Kautiainen, H. & Korhonen, P. E. Non-melancholic depressive symptoms increase risk for incident cardiovascular disease: A prospective study in a primary care population at risk for cardiovascular disease and type 2 diabetes. J. Psychosomatic Res. 129, 109887 (2020).
Ford, C. D. et al. Psychosocial factors are associated with blood pressure progression among african americans in the Jackson heart study. Am. J. Hypertens. 29, 913–924 (2016).
Jeon, S. W. & Kim, Y.-K. Cognitive dimensions of depression: Assessment, neurobiology, and treatment. In Understanding Depression: Volume 2. Clinical Manifestations, Diagnosis and Treatment (ed. Kim, Y.-K.) 151–160 (Springer, 2018).
Cole, S. R. et al. Illustrating bias due to conditioning on a collider. Int. J. Epidemiol. 39, 417–420 (2010).